IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pieris Pharmaceuticals Inc

CUSIP: 720795103 | 296 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

Orange Investment Advisors, Inc.14,000
0.0% of portfolio›$2.4K
StyleTurnoverLocationFiled
Orange Investment Advisors, Inc.
14,000$2.4K0.0%CoreLowGoshen, NY2024-07-02